The researchers found that TIS-competent lymphomas, but not TIS-incompetent lymphomas lacking the H3K9 histone methyltransferase Suv39h1, exhibited increased glucose utilization and higher ATP production after senescence-inducing chemotherapy. This evidence concerns the gene PRDM9 and lymphoma.